Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-25

Clinical Trial Update: A Randomized, Open Label, Prospective Study to Explore the Clinical Characteristics of Oral MNK155 and Norco 7.5mg/325 When Used for the Treatment of Moderate to Severe Post Operative Pain [Phase 3]

View source ↗

Summary

A randomized, open-label Phase 3 trial evaluating oral MNK155 in combination with Norco (hydrocodone/acetaminophen) for moderate to severe postoperative pain ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MNK155
  • Norco 7.5 mg/325 mg (hydrocodone/acetaminophen)

Snippet

Sponsor: Neil Singla | Conditions: Post Operative Pain | Phase 3 | Status: TERMINATED